Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer

Carcinogenesis

Volumn 33, Issue 3, 2012, Pages 604-612

  Shen, Jie ^a   Wang, Dan ^a   Gregory, Steven R ^a   Medico, Leonard ^a   Hu, Qiang ^a   Yan, Li ^a   Odunsi, Kunle ^a   Lele, Shashikant B ^a   Ambrosone, Christine B ^a   Liu, Song ^a   Zhao, Hua ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

EID: 84863251380     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs008     Document Type: Article

References (44)

1. Yancik, R. (1993) Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer, 71, 517-523.
2. Narod, S.A. et al. 1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am. J. Hum. Genet., 156, 254-264.
3. Ford, D. et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 62, 676-689.
4. Easton, D.F. et al. (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet., 52, 678-701.
5. Lynch, H.T. et al. (1982) Surveillance and management of patients at high genetic risk for ovarian carcinoma. Obstet. Gynecol., 59, 589-596.
6. Bolton, K.L. et al. (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet., 42, 880-884.
7. Goode, E.L. et al. (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet., 42, 874-879.
8. Song, H. et al. (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat. Genet., 41, 996-1000.
9. Freedman, M.L. et al. (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat. Genet., 43, 513-518.
10. Kim, V.N. et al. (2006) Genomics of microRNA. Trends Genet., 22, 165-173.
11. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet., 12, 861-874.
12. Esquela-Kerscher, A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Genet., 6, 259-269.
13. Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
14. Shahab, S.W. et al. (2011) Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. PLoS One, 6, e22508.
15. Iorio, M.V. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
16. Zhang, L. et al. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc. Natl Acad. Sci. USA, 105, 7004-7009.
17. Permuth-Wey, J. et al. (2011) LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res., 71, 3896-3903.
18. Shen, J. et al. (2008) A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis, 29, 1963-1966.
19. Schadt, E.E. et al. (2003) Genetics of gene expression surveyed in maize, mouse and man. Nature, 422, 297-302.
20. Heinzen, E. et al. (2008) Tissue specific genetic control of gene expression and alternative splicing: implications for the study of human complex traits. PLoS Biol., 6, e1000001.
21. Morley, M. et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature, 430, 743-747.
22. Borel, C. et al. (2011) Identification of cis- and trans-regulatory variation modulating microRNA expression levels in human fibroblasts. Genome Res., 21, 68-73.
23. Smyth, G.K. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, R3.
24. Benjamini, Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B, 57, 289-300.
25. Eisen, M.B. et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95, 14863-14868.
26. Slawski, M. et al. (2008) CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics, 9, 439.
27. Dudoit, S. et al. (2003) Classification in microarray experiments. In Speed T. (ed) Statistical Analysis of Gene Expression Microarray Data. 1st edn. Chapman and Hall/CRC, 93-158.
28. Stranger, B.E. et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315, 848-853.
29. Stranger, B.E. et al. (2007) Population genomics of human gene expression. Nat. Genet., 39, 1217-1224.
30. Montgomery, S.B. et al. (2010) Transcriptome genetics using second generation sequencing in a Caucasian population. Nature, 464, 773-777.
31. Landgraf, P. et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-1414.
32. Dixon, A.L. et al. (2007) A genome-wide association study of global gene expression. Nat. Genet., 39, 1202-1207.
33. Göring, H.H. et al. (2007) Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat. Genet., 39, 1208-1216.
34. Duan, S. et al. (2008) Genetic architecture of transcript-level variation in humans. Am. J. Hum. Genet., 82, 1101-1113.
35. Olive, V. et al. (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol., 42, 1348-1354.
36. Ota, A. et al. (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res., 64, 3087-3095.
37. Volinia, S. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
38. Petrocca, F. et al. (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res., 68, 8191-8194.
39. Hossain, A. et al. (2006) Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol., 26, 8191-8201.
40. Zhang, B. et al. (2007) MicroRNAs as oncogenes and tumor suppressors. Dev. Biol., 302, 1-12.
41. Fan, X. et al. (2010) miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim. Biophys. Sin. (Shanghai), 42, 318-324.
42. Nam, E.J. et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res., 14, 2690-2695.
43. Lu, Y. et al. (2009) Amplification and overexpression of Hsa-miR-30b, HsamiR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS One, 4, e6159.
44. Wu, J. et al. (2010) The role of BRCA1 in DNA damage response. Protein Cell, 1, 117-123.